Stock listing

Livzon Pharmaceutical Group, Inc. Class A

Selected listing: A1XCAW · LSX · EUR · DE

Livzon Pharmaceutical Group, Inc. Class A (LS Exchange: A1XCAW), Health Technology. Latest release Aug 22, 2023: Livzon Pharmaceutical : Interim Report 2023.

A1XCAW:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A1XCAW
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

About Livzon Pharmaceutical Group, Inc. Class A

The company is involved in the pharmaceutical industry, focusing on the development and production of various medical products. Livzon is committed to advancing healthcare solutions and improving patient outcomes through its innovative offerings.

Latest news from Livzon Pharmaceutical Group, Inc. Class A

Livzon Pharmaceutical : Interim Report 2023

August 22, 2023

Livzon Pharmaceutical : Interim Report 2022

August 9, 2022

Livzon Pharmaceutical : 2022 FIRST QUARTERLY REPORT

April 21, 2022

Livzon Pharmaceutical : was recognized as the National Enterprise Technology Center with High Scores

April 20, 2022

Livzon Pharmaceutical : A Recombinant SARS-Cov-2 Fusion Protein Vaccine (V-01) developed and manufactured by Livzon has shown good protective effects against the Omicron variant in a phase III clinical booster trial

April 20, 2022

All Livzon Pharmaceutical Group, Inc. Class A news →

Research Livzon Pharmaceutical Group, Inc. Class A

Livzon Pharmaceutical Group, Inc. Class A company profile

View the public company page for Livzon Pharmaceutical Group, Inc. Class A on 6ix.

Livzon Pharmaceutical Group, Inc. Class A news

Read company news and market updates connected to Livzon Pharmaceutical Group, Inc. Class A.

Livzon Pharmaceutical Group, Inc. Class A investor events

Find investor webinars, events, and replay context for Livzon Pharmaceutical Group, Inc. Class A.